comprehensive -WSS

comprehensive

author：fashion 2025-09-06 09:44:54 - browse：1197

Vials and packaging for Leqembi, a new Alzheimer's medication approved in the U.S., but not yet in Europe. Illustration: Alex Hogan/STAT; Photo: Eisai via AP

LONDON — Starting Sunday, Alzheimer’s specialists will gather for a major conference in Amsterdam, convening at a time when the field, depending on which expert you ask, has some rare momentum behind it, with new therapies starting to show benefits for patients.

But despite the hard-won victories, the arrival of the new therapies presents a new set of challenges in Europe as countries plan for their possible rollouts, scientists and doctors told STAT.

Health systems will have to adapt to diagnose people earlier and monitor them for side effects associated with the treatments. If their medicines win European approval, companies will have to strike reimbursement deals in all member states, a process that often leaves some countries waiting years for new drugs to become available. The hurdles mean the therapies will likely be offered only at certain centers initially, constraining how many patients have access to them, doctors from across Europe said.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： How one medical school became remarkably diverse
Next article： Biden report: The neurospychology of memory and aging

WSS

Senators start work on Medicare physician payment reform

Readout LOUD podcast: How biotech is using artificial intelligence

Adidas to release second batch of Yeezy sneakers after breakup with Ye

Typhoon Doksuri makes landfall in China after bringing deadly landslides to Philippines

Europe is fastest

Biden has enormous polling lead in Democratic primary, despite challenge from RFK Jr.

entertainment

comprehensive

focus

ChatGPT in medicine: STAT answers readers' burning questions

Poland's lawmakers approve a divisive law on Russian influence

Peter Hotez and the public health issue of online harassment

KalVista pill reduced swelling 'attacks' caused by genetic disease

United colonoscopy coverage change 'may cost lives,' doctors say

Trump team launching legal defense fund to help pay legal bills

Continuity nursing helped my family in our darkest PICU moments

Biden has enormous polling lead in Democratic primary, despite challenge from RFK Jr.

BioMarin wins approval for gene therapy to treat hemophilia A

Many immigrants are left out of maternal health programs

hotspot

9 mass shootings over the weekend rock US cities, leaving 5 dead, 56 injured

What should King Charles tell the public about his cancer?

Medicare Advantage proposed rates disappoint insurers

American TikTok star stuck in Dubai for months following rental car altercation

Teacher posts viral 'school supply rant' with advice for parents

The dental labor crisis is a moment of opportunity

focus

focus

hotspot

hotspot